PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

Abstract
No abstract available
Funding Information
  • AstraZeneca
  • Meso Scale Diagnostics
  • Genzyme
  • Otsuka America
  • Merck
  • Bayer HealthCare
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Ipsen
  • AbbVie
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Abbott Laboratories
  • Amgen
  • Sanofi